| Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia GA Calin, CD Dumitru, M Shimizu, R Bichi, S Zupo, E Noch, H Aldler, ... Proceedings of the national academy of sciences 99 (24), 15524-15529, 2002 | 7114 | 2002 |
| miR-15 and miR-16 induce apoptosis by targeting BCL2 A Cimmino, GA Calin, M Fabbri, MV Iorio, M Ferracin, M Shimizu, ... Proceedings of the National Academy of Sciences 102 (39), 13944-13949, 2005 | 4855 | 2005 |
| Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National … M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ... Blood, The Journal of the American Society of Hematology 111 (12), 5446-5456, 2008 | 3907 | 2008 |
| A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia GA Calin, M Ferracin, A Cimmino, G Di Leva, M Shimizu, SE Wojcik, ... New England Journal of Medicine 353 (17), 1793-1801, 2005 | 3152 | 2005 |
| Idelalisib and rituximab in relapsed chronic lymphocytic leukemia RR Furman, JP Sharman, SE Coutre, BD Cheson, JM Pagel, P Hillmen, ... New England Journal of Medicine 370 (11), 997-1007, 2014 | 2176 | 2014 |
| Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia AW Roberts, MS Davids, JM Pagel, BS Kahl, SD Puvvada, JF Gerecitano, ... New England Journal of Medicine 374 (4), 311-322, 2016 | 2006 | 2016 |
| Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia JC Byrd, JR Brown, S O'Brien, JC Barrientos, NE Kay, NM Reddy, ... New England Journal of Medicine 371 (3), 213-223, 2014 | 1916 | 2014 |
| MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias GA Calin, CG Liu, C Sevignani, M Ferracin, N Felli, CD Dumitru, ... Proceedings of the National Academy of Sciences 101 (32), 11755-11760, 2004 | 1778 | 2004 |
| Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia JA Burger, A Tedeschi, PM Barr, T Robak, C Owen, P Ghia, O Bairey, ... New England Journal of Medicine 373 (25), 2425-2437, 2015 | 1694 | 2015 |
| iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ... Blood, The Journal of the American Society of Hematology 131 (25), 2745-2760, 2018 | 1585 | 2018 |
| CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment JA Burger, TJ Kipps Blood 107 (5), 1761-1767, 2006 | 1480 | 2006 |
| Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia A Rosenwald, AA Alizadeh, G Widhopf, R Simon, RE Davis, X Yu, L Yang, ... The Journal of experimental medicine 194 (11), 1639-1648, 2001 | 1434 | 2001 |
| ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia LZ Rassenti, L Huynh, TL Toy, L Chen, MJ Keating, JG Gribben, ... New England Journal of Medicine 351 (9), 893-901, 2004 | 1195 | 2004 |
| Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, SL Allen, P Schulman, ... The Journal of clinical investigation 102 (8), 1515-1525, 1998 | 1126 | 1998 |
| Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1 JA Burger, N Tsukada, M Burger, NJ Zvaifler, M Dell'Aquila, TJ Kipps Blood, The Journal of the American Society of Hematology 96 (8), 2655-2663, 2000 | 1000 | 2000 |
| MiR-15a and miR-16-1 cluster functions in human leukemia GA Calin, A Cimmino, M Fabbri, M Ferracin, SE Wojcik, M Shimizu, ... Proceedings of the National Academy of Sciences 105 (13), 5166-5171, 2008 | 986 | 2008 |
| Venetoclax–rituximab in relapsed or refractory chronic lymphocytic leukemia JF Seymour, TJ Kipps, B Eichhorst, P Hillmen, J D’Rozario, S Assouline, ... New England Journal of Medicine 378 (12), 1107-1120, 2018 | 938 | 2018 |
| Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease AW Roberts, JF Seymour, JR Brown, WG Wierda, TJ Kipps, SL Khaw, ... Journal of Clinical Oncology 30 (5), 488, 2012 | 933 | 2012 |
| Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas GA Calin, C Liu, M Ferracin, T Hyslop, R Spizzo, C Sevignani, M Fabbri, ... Cancer cell 12 (3), 215-229, 2007 | 914 | 2007 |
| Chronic lymphocytic leukaemia TJ Kipps, FK Stevenson, CJ Wu, CM Croce, G Packham, WG Wierda, ... Nature reviews Disease primers 3 (1), 1-22, 2017 | 860* | 2017 |
